skip to content

Cambridge Academy of Therapeutic Sciences

 

 

Practical Application of Toxicology in Drug Development Course

Date: September 13th – 17th 2021

Location: This course will take place online. Pre-recorded lectures will be available prior to the live sessions.

 

This highly acclaimed course will provide training in toxicology as applied in drug development to scientists from all parts of the world. Participants will obtain an overall understanding of the principles of non-clinical safety evaluation with an emphasis on the practical application of these principles and the interpretation of non-clinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective.

The course is intended to benefit those from both biotechnology and pharmaceutical companies as well as CROs working with either small or large molecules, along with those from regulatory agencies and academia who are interested in toxicology and its application in the safety assessment of drugs and medical products. Early career scientists seeking a more in-depth knowledge and understanding of the role of toxicology in safety assessment will also benefit. The course is suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) looking to make a career change to work in drug safety assessment.

The course is recognised by EUROTOX as providing 37 hours of CPD and approved by the Royal Society of Biology for 96 CPD credits.

 

On-demand access to the presentations will be available to registrants for unlimited viewing no later than August 30th until September 25th 2021.

Virtual Features

•             Virtual interactive case studies and break out groups

•             Live Q&A Sessions with Speakers

•             Recorded lectures and associated course materials with unlimited on-demand viewing

 

The course will take place from September 13th to 17th 2021 and will be held virtually. Pre-recorded lectures will be made available to registrants for unlimited viewing no later than August 30th 2021. Live Q&A sessions will be held with the speakers on the week of September 13th to 17th 2021 (Final 2-3 hour session times TBC) This annual course is a collaboration between the American College of Toxicology (ACT), the British Toxicology Society (BTS) and the Cambridge Alliance on Medicines Safety (CAMS).

 

Registration

Registration is now open for the course until September 12th 2021.

To register your place please follow the link here to a secure payment page.

 

Registration rates:

2021 Registration fees             

ACT/BTS Member                                 £950.00                                                       

Student                                               £950.00                                                        

Non-Member                                      £1,250.00                                                    

Government                                         £950.00                                                        

                                               

Group (3 or more from same company)

ACT/BTS Member Group Rate*              £850.00                                                  

Non-Member Group Rate*                   £1,150.00                                                   

*If you wish to avail of the group rate please contact the organisers at the Cambridge Alliance on Medicines Safety (patdd@admin.cam.ac.uk) who will be able to process your request.

Note: Payments will be processed in GBP £

Refund Policy: We will not be able to offer refunds for virtual courses. Health-related refunds will be considered on a case-by-case basis. These special cancellation requests should be submitted in writing to patdd@admin.cam.ac.uk. A £75 processing fee will be charged for cancellations.

 

The course organisers recognise the challenges faced by researchers in low-and-middle income countries (LMIC), including reduced access to training opportunities and have made available a limited number of bursaries to cover the cost of registration for those who may not otherwise be able to join. Applicants should be from an LMIC country and working at a LMIC based research or government organisation.

 

If you would like to be considered for PATDD bursary please the following to patdd@admin.cam.ac.uk by 12:00 BST on August 13th 2021:

1)- A letter of application stating why you would like to attend this course and what the benefit would be to your career and your organisation.

2)- A letter of support from your employer outlining your suitability for joining this course and the benefits it would bring. (Please note, letters of support should be submitted from an organisational email address)

 

 

Course Material

Access to the PATDD course material will be provided approximately two weeks before the start of the course. Access to this material will be restricted to those who have registered in full.

 

 

Course overview

 

Monday September 13th 2021

Overview of Drug Discovery and Development;  Ruth Roberts, Apconix

Pharmacology - Rob Wallis, Safety Pharmacology Consultant

Safety Pharmacology - Rob Wallis, Safety Pharmacology Consultant

DMPK and ADME, Concepts and Technologies - Kunal Taskar, GSK

 

Tuesday September 14th 2021

Pathology - Vasanthi Mowat, Labcorp

Clinical Pathology - Jo Harding and Peter Cotton, Astra Zeneca

Organ Systems; Part I - John Foster, Senior Pathology Consultant

Organ Systems; Part II - Matt Jacobsen, AstraZeneca

 

Wednesday September 15th 2021

Genetic Toxicology - George Johnson, Swansea University

Carcinogenicity - Nigel Roome, Toxicology and Toxicologic Pathology Consultant

Reproduction/Developmental Toxicology – Gary Chellman, Charles River Laboratories

Safety of Biotechnology Products - Lolke de Haan, ADC Therapeutics

 

Thursday September 16th 2021

Regulatory Safety Studies for Cell and Gene Therapy Products - Jan Klapwijk, Cornelis Consulting

Immunotoxicology - Marc Pallardy, Université Paris-Saclay 

Risk Assessment - Ernie Harpur, Newcastle University

Regulatory Toxicology - David Jones, MHRA

 

Friday September 17th 2021

Regulatory Case Studies – Full details TBC

 

This course is kindly supported by Charles River Laboratories